Parvez Mulani
AbbVie (United States)(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Health Systems, Economic Evaluations, Quality of Life, Adolescent and Pediatric Healthcare
Most-Cited Works
- → Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa(2012)407 cited
- → Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study(2008)372 cited
- → Comparative Effectiveness Without Head-to-Head Trials(2010)358 cited
- → Systematic review: the costs of ulcerative colitis in Western countries(2010)291 cited
- → Adalimumab Induces Deep Remission in Patients With Crohn's Disease(2013)245 cited
- → Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer(2008)213 cited
- → Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial(2008)212 cited
- → Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment(2014)206 cited
- → The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial(2010)194 cited
- → Risks of developing psychiatric disorders in pediatric patients with psoriasis(2012)194 cited